Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.86%
SPX
+1.11%
IXIC
+1.69%
FTSE
+1.85%
N225
+5.24%
AXJO
+2.24%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Stocks
Health Care
ino
Inovio Pharmaceuticals
NASDAQ: INO
+0.01 (+0.29%)
1.745
USD
At close at Apr 01, 16:06 UTC
Summary
News
Signals
Benchmarks
Financials

Overview

Loading chart...

Key Stats

Market Cap
93.21M
Dividend Yield
0.00%
P/E Ratio
-1.10
EPS
-3.99
Revenue
217.76K
Avg. Volume
880.31K

Recently from Cashu

publisher logo
Cashu

Inovio Pharmaceuticals Faces Class Action for Alleged Misleading Statements on Manufacturing Capabilities

2 days ago
publisher logo
Cashu

Inovio Pharmaceuticals Faces Class Action Lawsuits Over Securities Fraud Allegations

6 days ago
publisher logo
Cashu

Inovio Pharmaceuticals Faces Class Action Lawsuits Over Allegations of Securities Fraud and Misrepresentation

6 days ago
Join our newsletter to keep up to date with us!

About

What does INO do?
Inovio Pharmaceuticals, based in San Diego, develops DNA medicines targeting infectious diseases, cancer, and HPV-related conditions, with key candidates including INO-3107 for recurrent respiratory papillomatosis. The company employs 122 people and utilizes CELLECTRA devices for DNA delivery.
Sector
💻 Health Care
IPO
CEO
Employees
134
Headquarters
California, USA
Website
http://www.inovio.com